HuGE Literature Finder
|
||
Records 1-30
|
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Clinical lymphoma, myeloma & leukemia 2018 Jun . Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung- |
|
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.
Blood cancer journal 2018 Jan 8 (1): 4. Saygin Caner, Hirsch Cassandra, Przychodzen Bartlomiej, Sekeres Mikkael A, Hamilton Betty K, Kalaycio Matt, Carraway Hetty E, Gerds Aaron T, Mukherjee Sudipto, Nazha Aziz, Sobecks Ronald, Goebel Christopher, Abounader Donna, Maciejewski Jaroslaw P, Advani Anjali |
|
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
Annals of hematology 2017 Jun . Heuser Michael, Gabdoulline Razif, Löffeld Patrick, Dobbernack Vera, Kreimeyer Henriette, Pankratz Mira, Flintrop Madita, Liebich Alessandro, Klesse Sabrina, Panagiota Victoria, Stadler Michael, Wichmann Martin, Shahswar Rabia, Platzbecker Uwe, Thiede Christian, Schroeder Thomas, Kobbe Guido, Geffers Robert, Schlegelberger Brigitte, Göhring Gudrun, Kreipe Hans-Heinrich, Germing Ulrich, Ganser Arnold, Kröger Nicolaus, Koenecke Christian, Thol Felicit |
|
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Leukemia 2017 06 31 (6): 1286-1295. Thol F, Klesse S, Köhler L, Gabdoulline R, Kloos A, Liebich A, Wichmann M, Chaturvedi A, Fabisch J, Gaidzik V I, Paschka P, Bullinger L, Bug G, Serve H, Göhring G, Schlegelberger B, Lübbert M, Kirchner H, Wattad M, Kraemer D, Hertenstein B, Heil G, Fiedler W, Krauter J, Schlenk R F, Döhner K, Döhner H, Ganser A, Heuser |
|
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
|
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Oncotarget 2016 Jul . Palomo Laura, Garcia Olga, Arnan Montse, Xicoy Blanca, Fuster Francisco, Cabezón Marta, Coll Rosa, Ademà Vera, Grau Javier, Jiménez Maria-José, Pomares Helena, Marcé Sílvia, Mallo Mar, Millá Fuensanta, Alonso Esther, Sureda Anna, Gallardo David, Feliu Evarist, Ribera Josep-Maria, Solé Francesc, Zamora Lurd |
|
EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
Journal of cancer research and clinical oncology 2016 May . Schäfer Vivien, Ernst Jana, Rinke Jenny, Winkelmann Nils, Beck James F, Hochhaus Andreas, Gruhn Bernd, Ernst Thom |
|
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Leukemia 2016 May . Gaidzik V I, Teleanu V, Papaemmanuil E, Weber D, Paschka P, Hahn J, Wallrabenstein T, Kolbinger B, Köhne C-H, Horst H A, Brossart P, Held G, Kündgen A, Ringhoffer M, Götze K, Rummel M, Gerstung M, Campbell P, Kraus J M, Kestler H A, Thol F, Heuser M, Schlegelberger B, Ganser A, Bullinger L, Schlenk R F, Döhner K, Döhner |
|
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 May . Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attil |
|
Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Blood 2015 Aug 126 (8): 1005-8. Dietrich Sascha, Hüllein Jennifer, Lee Stanley Chun-Wei, Hutter Barbara, Gonzalez David, Jayne Sandrine, Dyer Martin J S, Ole? Ma?gorzata, Else Monica, Liu Xiyang, S?abicki Miko?aj, Wu Bian, Troussard Xavier, Dürig Jan, Andrulis Mindaugas, Dearden Claire, von Kalle Christof, Granzow Martin, Jauch Anna, Fröhling Stefan, Huber Wolfgang, Meggendorfer Manja, Haferlach Torsten, Ho Anthony D, Richter Daniela, Brors Benedikt, Glimm Hanno, Matutes Estella, Abdel Wahab Omar, Zenz Thorst |
|
Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population.
Annals of laboratory medicine 2015 May 35 (3): 288-97. Park Sang Hyuk, Lee Hyun Ji, Kim In-Suk, Kang Jeong-Eun, Lee Eun Yup, Kim Hyeoung-Joon, Kim Yeo-Kyeoung, Won Jong-Ho, Bang Soo Mee, Kim Hawk, Song Moo-Kon, Chung Joo Seop, Shin Ho-J |
|
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
|
Mutational spectrum of adult T-ALL.
Oncotarget 2015 Feb 6 (5): 2754-66. Neumann Martin, Vosberg Sebastian, Schlee Cornelia, Heesch Sandra, Schwartz Stefan, Gökbuget Nicola, Hoelzer Dieter, Graf Alexander, Krebs Stefan, Bartram Isabelle, Blum Helmut, Brüggemann Monika, Hecht Jochen, Bohlander Stefan K, Greif Philipp A, Baldus Claudia |
|
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.
Nature communications 2015 6 5901. Gerstung Moritz, Pellagatti Andrea, Malcovati Luca, Giagounidis Aristoteles, Porta Matteo G Della, Jädersten Martin, Dolatshad Hamid, Verma Amit, Cross Nicholas C P, Vyas Paresh, Killick Sally, Hellström-Lindberg Eva, Cazzola Mario, Papaemmanuil Elli, Campbell Peter J, Boultwood Jacqueli |
|
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
|
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
Leukemia 2014 Sep 28 (9): 1804-10. Guglielmelli P, Lasho T L, Rotunno G, Score J, Mannarelli C, Pancrazzi A, Biamonte F, Pardanani A, Zoi K, Reiter A, Duncombe A, Fanelli T, Pietra D, Rumi E, Finke C, Gangat N, Ketterling R P, Knudson R A, Hanson C A, Bosi A, Pereira A, Manfredini R, Cervantes F, Barosi G, Cazzola M, Cross N C P, Vannucchi A M, Tefferi |
|
TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.
International journal of hematology 2014 Jul 100 (1): 96-104. Tian Xiaopeng, Xu Yang, Yin Jia, Tian Hong, Chen Suning, Wu Depei, Sun Aini |
|
Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia.
Neoplasia (New York, N.Y.) 2014 Jun 16 (6): 481-8. Kao Hsiao-Wen, Liang Der-Cherng, Wu Jin-Hou, Kuo Ming-Chung, Wang Po-Nan, Yang Chao-Ping, Shih Yu-Shu, Lin Tung-Huei, Huang Yu-Hui, Shih Lee-Yu |
|
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.
Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
|
Mutations and prognosis in primary myelofibrosis.
Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
|
Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
|
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes.
Leukemia research 2013 Mar 37 (3): 305-11. Wang Jieyu, Ai Xiaofei, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Zhang Yue, Xiao Zhiji |
|
[Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2013 Jan 21 (1): 1. Yin J, Sun AN, Tian XP, Tian H, Wang RX, Yang Z, Wang XL, Wu DP, Qiu HY, Pan JL, Cen JN, Liang JY, Chen SN |
|
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
|
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
PloS one 2013 8 (4): e61341. Wang Xiuli, Dai Haiping, Wang Qian, Wang Qinrong, Xu Yang, Wang Ying, Sun Aining, Ruan Jia, Chen Suning, Wu Dep |
|
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
Haematologica 2012 Oct 97 (10): 1582-5. Schnittger Susanne, Bacher Ulrike, Eder Christiane, Dicker Frank, Alpermann Tamara, Grossmann Vera, Kohlmann Alexander, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
|
EZH2 mutational status predicts poor survival in myelofibrosis.
Blood 2011 Nov 118 (19): 5227-34. Guglielmelli Paola, Biamonte Flavia, Score Joannah, Hidalgo-Curtis Claire, Cervantes Francisco, Maffioli Margherita, Fanelli Tiziana, Ernst Thomas, Winkelman Nils, Jones Amy V, Zoi Katerina, Reiter Andreas, Duncombe Andrew, Villani Laura, Bosi Alberto, Barosi Giovanni, Cross Nicholas C P, Vannucchi Alessandro |
|
Clinical effect of point mutations in myelodysplastic syndromes.
The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
|
Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias.
Leukemia research 2011 Jan 35 (1): e6-7. Park Sang Wook, Chung Nak Gyun, Eom Hyeon Seok, Yoo Nam Jin, Lee Sug Hyu |
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: